Literature DB >> 18171426

FOXO transcription factors in ageing and cancer.

E L Greer1, A Brunet.   

Abstract

Ageing is associated with an increased onset of cancer. Understanding the molecular mechanisms that underlie the age dependency of cancer will have important implications for preventing and treating this pathology. The signalling pathway connecting insulin and FOXO transcription factors provides the most compelling example for a conserved genetic pathway at the interface between ageing and cancer. FOXO transcription factors (FOXO) promote longevity and tumour suppression. FOXO transcription factors are directly phosphorylated in response to insulin/growth factor signalling by the protein kinase Akt, thereby causing their sequestration in the cytoplasm. In the absence of insulin/growth factors, FOXO factors translocate to the nucleus where they trigger a range of cellular responses, including resistance to oxidative stress, a phenotype highly coupled with lifespan extension. FOXO factors integrate stress stimuli via phosphorylation, acetylation and mono-ubiquitination of a series of regulatory sites. Understanding how FOXO proteins integrate environmental conditions to control specific gene expression programmes will be pivotal in identifying ways to slow the onset of cancer in ageing individuals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18171426     DOI: 10.1111/j.1748-1716.2007.01780.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  85 in total

Review 1.  Reactive Oxygen Species: the Dual Role in Physiological and Pathological Conditions of the Human Body.

Authors:  Sanaa K Bardaweel; Mustafa Gul; Muhammad Alzweiri; Aman Ishaqat; Husam A ALSalamat; Rasha M Bashatwah
Journal:  Eurasian J Med       Date:  2018-10

2.  Involvement of the up-regulated FoxO1 expression in follicular granulosa cell apoptosis induced by oxidative stress.

Authors:  Ming Shen; Fei Lin; Jiaqing Zhang; Yiting Tang; Wei-Kang Chen; Honglin Liu
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

Review 3.  New insights for FOXO and cell-fate decision in HIV infection and HIV associated neurocognitive disorder.

Authors:  Min Cui; Yunlong Huang; Yong Zhao; Jialin Zheng
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

4.  Juvenile hormone regulates body size and perturbs insulin signaling in Drosophila.

Authors:  Christen Kerry Mirth; Hui Yuan Tang; Sasha C Makohon-Moore; Samy Salhadar; Rewatee H Gokhale; Raechel D Warner; Takashi Koyama; Lynn M Riddiford; Alexander W Shingleton
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

Review 5.  Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging.

Authors:  Vinodkumar B Pillai; Nagalingam R Sundaresan; Mahesh P Gupta
Journal:  Circ Res       Date:  2014-01-17       Impact factor: 17.367

Review 6.  Somatotropic signaling: trade-offs between growth, reproductive development, and longevity.

Authors:  Andrzej Bartke; Liou Y Sun; Valter Longo
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 7.  From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis.

Authors:  Stavros C Manolagas
Journal:  Endocr Rev       Date:  2010-01-05       Impact factor: 19.871

8.  PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressor.

Authors:  Octavian Bucur; Andreea Lucia Stancu; Maria Sinziana Muraru; Armelle Melet; Stefana Maria Petrescu; Roya Khosravi-Far
Journal:  Discoveries (Craiova)       Date:  2014 Apr-Jun

9.  Integration of Insulin receptor/Foxo signaling and dMyc activity during muscle growth regulates body size in Drosophila.

Authors:  Fabio Demontis; Norbert Perrimon
Journal:  Development       Date:  2009-02-11       Impact factor: 6.868

10.  Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice.

Authors:  Wei Yao; Weiwei Dai; Mohammad Shahnazari; Aaron Pham; Zhiqiang Chen; Haiyan Chen; Min Guan; Nancy E Lane
Journal:  PLoS One       Date:  2010-07-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.